5 Patents
- US125288662026Recombinant Protein Targeting PD-L1 and VEGF and Compositions Thereof
IMMUNEONCO BIOPHARMACEUTICALS (SHANGHAI) Inc.
0 cites - US119266752024Antibodies Binding CD24, Preparation and Use Thereof
IMMUNEONCO BIOPHARMACEUTICALS (SHANGHAI) Inc.
0 cites - US118914492024Recombinant Fusion Proteins Targeting CD47 and CD24, Preparation and Use Thereof
IMMUNEONCO BIOPHARMACEUTICALS (SHANGHAI) Inc.
0 cites - US116728592023Recombinant Fusion Proteins Targeting CD47 and PD-L1, Preparation and Use Thereof
IMMUNEONCO BIOPHARMACEUTICALS (SHANGHAI) Inc.
0 cites - US116135842023Antibodies Binding CD70, Preparation and Use Thereof
IMMUNEONCO BIOPHARMACEUTICALS (SHANGHAI) Inc.
0 cites